How The Insulet (PODD) Narrative Is Shifting With Omnipod 5 And Rising Competition

Insulet’s modeled fair value per share has been tweaked from US$354.40 to US$354.12, a very small adjustment that still ...
MedTech Dive

Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps

The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause ...

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Outcomes from EVOLUTION 2 study include 68% time in range with no boluses Diverse multicenter feasibility study highlights ...
The Motley Fool

Top Commercial Real Estate Stocks

Commercial real estate stocks, often structured as REITs, offer dividends that attract income investors. Investing in commercial real estate stocks like Kilroy Realty allows exposure to diverse ...
The Business Journals

Commercial Real Estate Sales News

Showcase your company news with guaranteed exposure both in print and online The San Francisco Business Times and the Silicon Valley Business Journal are proud to present… Celebrate owners/developers, ...

Diabetics who rely on glucose monitors are alarmed by recall linked to 7 deaths

A manufacturing problem in Abbott glucose sensors for diabetes patients has been tied to at least seven deaths and hundreds ...